Michael S Stevens1, Jennifer Geduld2, Michael Libman3, Brian J Ward3, Anne E McCarthy4, Jean Vincelette5, Wayne Ghesquiere6, Jan Hajek7, Susan Kuhn8, David O Freedman9, Kevin C Kain10, Andrea K Boggild11. 1. Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ont. 2. Travel and Migration Health Division, Infectious Disease Prevention and Control Branch, Public Health Agency of Canada, Ottawa, Ont. 3. Division of Infectious Diseases, Department of Microbiology, and JD Maclean Centre for Tropical Diseases, McGill University Health Centre, Montréal, Que. 4. Tropical Medicine and International Health Clinic, Division of Infectious Diseases, Ottawa Hospital and the University of Ottawa, Ottawa, Ont. 5. Hôpital Saint-Luc du Centre Hospitalier de l'Université de Montréal, Montréal, Que. 6. Infectious Diseases, Vancouver Island Health Authority, Department of Medicine, University of British Columbia, Victoria, BC. 7. Division of Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, BC. 8. Section of Pediatric Infectious Diseases, Departments of Pediatrics and Medicine, Alberta Children's Hospital and the University of Calgary, Calgary, Alta. 9. UAB Travelers Health Clinic with the Gorgas Center for Geographic Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, Alabama. 10. SAR Laboratories, Sandra Rotman Centre for Global Health, Toronto, Ont. ; Tropical Disease Unit, Division of Infectious Diseases, Department of Medicine, University Health Network and the University of Toronto, Toronto, Ont. 11. Tropical Disease Unit, Division of Infectious Diseases, Department of Medicine, University Health Network and the University of Toronto, Toronto, Ont. ; Public Health Ontario Laboratories, Public Health Ontario, Toronto, Ont.
Abstract
BACKGROUND: There is a lack of multicentre analyses of the spectrum of dermatologic illnesses acquired by Canadian travellers and immigrants. Our objective for this study was to provide a comprehensive, Canada-specific surveillance summary of travel-related dermatologic conditions in a cohort of returned Canadian travellers and immigrants. METHODS: Data for Canadian travellers and immigrants with a primary dermatologic diagnosis presenting to CanTravNet sites between September 2009 and September 2012 were extracted and analyzed. Data were collected using the GeoSentinel data platform. This network comprises 56 specialized travel and tropical medicine clinics, including 6 Canadian sites (Vancouver, Calgary, Toronto, Ottawa and Montréal), that contribute anonymous, de-linked, clinician- and questionnaire-based travel surveillance data on all ill travellers examined to a centralized Structure Query Language database. Results were analyzed according to reason for most recent ravel: immigration (including refugee); tourism; business; missionary/volunteer/research and aid work; visiting friends and relatives; and other, which included students, military personnel and medical tourists. RESULTS: During the study period, 6639 patients presented to CanTravNet sites across Canada and 1076 (16.2%) received a travel-related primary dermatologic diagnosis. Arthropod bites (n = 162, 21.5%), rash (n = 141, 18.7%), cutaneous larva migrans (n = 98, 13.0%), and skin and soft tissue infection (n = 92, 12.2%) were the most common dermatologic diagnoses or diagnostic bundles issued to returning Canadian tourists (n = 754, 70.1% of total sample). Patients travelling for the purpose of immigration (n = 63, 5.9%) were significantly more likely to require inpatient management of their dermatologic diagnoses (p < 0.001) than those travelling for other purposes. INTERPRETATION: This analysis of surveillance data details the spectrum of travel-related dermatological conditions among returning Canadian travellers in this cohort, and provides an epidemiologic framework for Canadian physicians encountering these patients.
BACKGROUND: There is a lack of multicentre analyses of the spectrum of dermatologic illnesses acquired by Canadian travellers and immigrants. Our objective for this study was to provide a comprehensive, Canada-specific surveillance summary of travel-related dermatologic conditions in a cohort of returned Canadian travellers and immigrants. METHODS: Data for Canadian travellers and immigrants with a primary dermatologic diagnosis presenting to CanTravNet sites between September 2009 and September 2012 were extracted and analyzed. Data were collected using the GeoSentinel data platform. This network comprises 56 specialized travel and tropical medicine clinics, including 6 Canadian sites (Vancouver, Calgary, Toronto, Ottawa and Montréal), that contribute anonymous, de-linked, clinician- and questionnaire-based travel surveillance data on all ill travellers examined to a centralized Structure Query Language database. Results were analyzed according to reason for most recent ravel: immigration (including refugee); tourism; business; missionary/volunteer/research and aid work; visiting friends and relatives; and other, which included students, military personnel and medical tourists. RESULTS: During the study period, 6639 patients presented to CanTravNet sites across Canada and 1076 (16.2%) received a travel-related primary dermatologic diagnosis. Arthropod bites (n = 162, 21.5%), rash (n = 141, 18.7%), cutaneous larva migrans (n = 98, 13.0%), and skin and soft tissue infection (n = 92, 12.2%) were the most common dermatologic diagnoses or diagnostic bundles issued to returning Canadian tourists (n = 754, 70.1% of total sample). Patients travelling for the purpose of immigration (n = 63, 5.9%) were significantly more likely to require inpatient management of their dermatologic diagnoses (p < 0.001) than those travelling for other purposes. INTERPRETATION: This analysis of surveillance data details the spectrum of travel-related dermatological conditions among returning Canadian travellers in this cohort, and provides an epidemiologic framework for Canadian physicians encountering these patients.
Authors: David O Freedman; Leisa H Weld; Phyllis E Kozarsky; Tamara Fisk; Rachel Robins; Frank von Sonnenburg; Jay S Keystone; Prativa Pandey; Martin S Cetron Journal: N Engl J Med Date: 2006-01-12 Impact factor: 91.245
Authors: Edith R Lederman; Leisa H Weld; Iqbal R F Elyazar; Frank von Sonnenburg; Louis Loutan; Eli Schwartz; Jay S Keystone Journal: Int J Infect Dis Date: 2008-03-14 Impact factor: 3.623
Authors: Kira Harvey; Douglas H Esposito; Pauline Han; Phyllis Kozarsky; David O Freedman; D Adam Plier; Mark J Sotir Journal: MMWR Surveill Summ Date: 2013-07-19
Authors: Andrea K Boggild; Jennifer Geduld; Michael Libman; Brian J Ward; Anne E McCarthy; Patrick W Doyle; Wayne Ghesquiere; Jean Vincelette; Susan Kuhn; David O Freedman; Kevin C Kain Journal: Open Med Date: 2014-02-11
Authors: Karin Leder; Joseph Torresi; Michael D Libman; Jakob P Cramer; Francesco Castelli; Patricia Schlagenhauf; Annelies Wilder-Smith; Mary E Wilson; Jay S Keystone; Eli Schwartz; Elizabeth D Barnett; Frank von Sonnenburg; John S Brownstein; Allen C Cheng; Mark J Sotir; Douglas H Esposito; David O Freedman Journal: Ann Intern Med Date: 2013-03-19 Impact factor: 25.391
Authors: Andrea K Boggild; Eric Caumes; Martin P Grobusch; Eli Schwartz; Noreen A Hynes; Michael Libman; Bradley A Connor; Sumontra Chakrabarti; Philippe Parola; Jay S Keystone; Theodore Nash; Adrienne J Showler; Mirjam Schunk; Hilmir Asgeirsson; Davidson H Hamer; Kevin C Kain Journal: J Travel Med Date: 2019-12-23 Impact factor: 8.490
Authors: Davidson H Hamer; Aisha Rizwan; David O Freedman; Phyllis Kozarsky; Michael Libman Journal: J Travel Med Date: 2020-12-23 Impact factor: 8.490